pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,782 catalysts · 4,779 phase readout · 2,339 8k filing · 286 earnings · 271 pdufa · 166 phase 2 completion · 71 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout4,779
  • 8k filing2,339
  • earnings286
  • pdufa271
  • phase 2 completion166
  • phase 1 completion71
phase 2 initiation
54
  • phase 1 initiation39
  • phase 1 2 completion33
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease3

    Date TBD

    50
    ›RECRUITINGphase readoutNCT05168605: Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

    Sponsor: University of Texas Southwestern Medical Center. Phase: NA. Conditions: Hypertension, Type 2 Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07181005: The Validity and Reliability of an Improved Paper Grasping Test for Stroke

    Sponsor: Sanko University. Phase: . Conditions: Stroke, Balance, Validity and Safety

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07469241: Study of MRI Guided Personal Chemoradiotherapy and Immunotherapy for Limited Advanced Esophageal Squamous Caicinoma.

    Sponsor: Fudan University. Phase: PHASE2. Conditions: Advanced Esophageal Squamous Cell Carcinoma, Unresectable Esophageal Squamous Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07168200: A Phase III Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy Versus Placebo Combined With Concurrent Chemoradiotherapy for the Treatment of Locally Advanced Cervical Cancer

    Sponsor: Shanghai Shengdi Pharmaceutical Co., Ltd. Phase: PHASE3. Conditions: Advanced Cervical Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03301792: Group Versus Traditional Prenatal Care for Diabetes

    Sponsor: Washington University School of Medicine. Phase: NA. Conditions: Pregnancy, Gestational Diabetes, Type 2 Diabetes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07422792: Anabolic Response To Intravenous Amino Acids In Chronic Intestinal Failure Patients

    Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Chronic Intestinal Failure, Intestinal Failure, Home Parenteral Nutrition

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06582771: A Study of Sotorasib in People With Non-Small Cell Lung Cancer

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Non Small Lung Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06961071: Parathyroid Allotransplant for Treatment of Hypoparathyroidism

    Sponsor: Peter Stock. Phase: PHASE1. Conditions: Hypoparathyroidism, Hypoparathyroidism Postprocedural, Hypoparathyroidism Post-surgical

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07318844: Stroke Volume at Rest and During Exercise in Healthy Volunteers

    Sponsor: Rigshospitalet, Denmark. Phase: NA. Conditions: Healthy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07476664: Acute Oroantral Communication Closure: Resorbable Collagen Membrane vs. Buccal Advancement Flap Outcomes

    Sponsor: Medical University of Silesia. Phase: NA. Conditions: Oroantral Communication, Acute Oroantral Communication, Oroantral Fistula, Post-extraction Maxillary Sinus Communication

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07452809: Results Between Robotic-assisted and Manual Total Knee Arthroplasty With Kinematic Alignment

    Sponsor: Jakub Błaszczyk. Phase: NA. Conditions: Knee Arthritis, Osteoarthritis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04868032: Gaining Optimism After Weight Loss Surgery (GOALS) II

    Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Bariatric Surgery

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07508098: Comparison of Efficacy of Topical Westerhoff Formula Cream Vs Topical 4% Hydroquinone for the Treatment of Melasma

    Sponsor: Pak Emirates Military Hospital. Phase: PHASE4. Conditions: Melasma (Facial Melasma)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05361798: A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Cancer Of Prostate

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03065387: Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Advanced Malignant Solid Neoplasm, EGFR Gene Amplification, EGFR Gene Mutation, ERBB2 Gene Amplification, ERBB2 Gene Mutation, ERBB3 Gene Mutation, ERBB4 Gene Mutation, KRAS Gene Mutation, Metastatic Malignant Solid Neoplasm, Refractory Malignant Solid Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06555393: Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study

    Sponsor: University of Alberta. Phase: PHASE1. Conditions: High Blood Sugar, High Blood Pressure, Overweight and Obesity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07440706: Continuous Glucose Monitoring With iCan i3 in Post-Bariatric Patients With Late Dumping Syndrome

    Sponsor: Kaiser Clinic and Hospital. Phase: NA. Conditions: Dumping Syndrome, Post-bariatric Hypoglycemia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07523204: Photobiomodulation Therapy for Scar Quality After Facial Wound Closure

    Sponsor: Hani M. Al-Kufi. Phase: NA. Conditions: Traumatic Facial Wounds

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06024304: InterTAN: Integrated Dual Screw Design Improve Biomechanics/Function Following Fixation Surgery

    Sponsor: Paul E. Matuszewski. Phase: NA. Conditions: Fracture of Hip

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05289804: Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment

    Sponsor: University of Dublin, Trinity College. Phase: PHASE1. Conditions: Mild Cognitive Impairment, Memory Impairment, Memory Disorders in Old Age

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05160233: Digital Treatments for Opioids and Other Substance Use Disorders in Primary Care

    Sponsor: Kaiser Permanente. Phase: NA. Conditions: Drug Use Disorders, Illicit Drug Use, Alcohol-Related Disorders, Opioid Use Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06932952: A Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients With Advanced or Metastatic Solid Tumors

    Sponsor: Byondis B.V.. Phase: PHASE1. Conditions: Solid Tumor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07441538: Optimizing the Timing for Facial Surgical Dressing Removal

    Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: NA. Conditions: Nevus, Seborrheic Keratosis (SK), Cyst, Lipoma, Scar

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05592938: Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

    Sponsor: University Health Network, Toronto. Phase: NA. Conditions: Breast Cancer, Breast Cancer Recurrent

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03352258: Effect of Low Dose Radiotherapy on Brain Amyloidosis in the Treatment of Alzheimer's Disease

    Sponsor: Valentina Garibotto. Phase: NA. Conditions: Alzheimer Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04481555: Eosinophil-guided Reduction of Inhaled Corticosteroids

    Sponsor: Chronic Obstructive Pulmonary Disease Trial Network, Denmark. Phase: PHASE4. Conditions: COPD, Inhaled Corticosteroid, Azithromycin, COPD Exacerbation, Pneumonia

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06643455: Mindfulness Intervention for Improving Nutrition in the Digital Kitchen Among Stage I-III Breast Cancer Survivors, MIND Trial

    Sponsor: Fred Hutchinson Cancer Center. Phase: NA. Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07318155: A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease

    Sponsor: Sirius Therapeutics Co., Ltd.. Phase: PHASE2. Conditions: Coronary Artery Disease (CAD), Peripheral Arterial Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03939026: Safety and Efficacy of ALLO-501 Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell or Follicular Lymphoma

    Sponsor: Allogene Therapeutics. Phase: PHASE1. Conditions: Relapsed/Refractory Large B Cell Lymphoma, Relapsed/Refractory Follicular Lymphoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05814055: The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence

    Sponsor: University of Florida. Phase: PHASE2. Conditions: Smoking

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07381426: Ferric Citrate in Iron Deficiency Anemia During Pregnancy

    Sponsor: Dhaka Medical College. Phase: PHASE3. Conditions: Anemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT03004326: Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

    Sponsor: Peter Merkel. Phase: . Conditions: Cryoglobulinemic Vasculitis (CV), Drug-induced Vasculitis, Eosinophilic Granulomatosis With Polyangiitis (EGPA), IgA Vasculitis, Isolated Cutaneous Vasculitis, Granulomatosis With Polyangiitis (GPA), Microscopic Polyangiitis (MPA), Polyarteritis Nodosa (PAN), Urticarial Vasculitis, Vasculitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07410026: Diagnostic and Therapeutic Efficacy and Safety of Enteroscopy in Pediatric Patients

    Sponsor: Shandong University. Phase: . Conditions: Small Bowel Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07519915: Improvement of Understanding of Pediatric Sacral Neuromodulation: Therapeutic Strategies and Outcome Variables

    Sponsor: Friedrich-Alexander-Universität Erlangen-Nürnberg. Phase: NA. Conditions: Gastrointestinal Motility Disorders in Children, Hirschsprung Disease, Constipation - Functional

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT00231400: Pompe Disease Registry Protocol

    Sponsor: Genzyme, a Sanofi Company. Phase: . Conditions: Glycogen Storage Disease Type II, Pompe Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07521592: Effect of Video-Based Versus Verbal Preoperative Information on Anxiety and Cortisol Levels in Elective Cesarean Section

    Sponsor: Elazıg Fethi Sekin Sehir Hastanesi. Phase: NA. Conditions: Preoperative Anxiety, Cesarean Section, Surgical Stress Response, Cortisol

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03173092: A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)

    Sponsor: Takeda. Phase: PHASE4. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT02106611: Tissue and Functional Assessment of Myocardial Injury in Hodgkin Lymphoma (HL) Survivors

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: . Conditions: Hodgkin Lymphoma Survivor

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05562271: Clinical Trial of Low-dose Radiation Therapy in Patients With Knee Osteoarthritis (LoRD-KNeA Trial)

    Sponsor: Seoul National University Hospital. Phase: NA. Conditions: Knee Osteoarthritis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07351864: Finerenone Plus SGLT2 Inhibitors in Heart Failure

    Sponsor: Mansoura University. Phase: PHASE4. Conditions: Heart Failure

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07316764: Eccentric Cycling in Multiple Sclerosis Rehabilitation

    Sponsor: University of Liege. Phase: NA. Conditions: Multiple Sclerosis, Rehabilitation, Neuro-Degenerative Disease, Neurorehabilitation

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07499609: Prevalence and Risk Factors for Hypertension and Recoarctation in Patients Operated for Aortic Coarctation

    Sponsor: Institut Saint Pierre. Phase: . Conditions: Aortic Coarctation, Retrospective Studies, Cohort Studies, Hypertension, Risk Factors, Infant, Newborn, Postoperative Complications, Reoperation, Mortality, Death, Cardiac Surgery

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04088409: A Study of Baricitinib (LY3009104) in Participants From 2 Years to Less Than 18 Years Old With Active JIA-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis

    Sponsor: Eli Lilly and Company. Phase: PHASE3. Conditions: Uveitis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05344599: Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome

    Sponsor: Vanderbilt University Medical Center. Phase: . Conditions: Postural Orthostatic Tachycardia Syndrome, Acute Hepatic Porphyria

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07417332: Determination of the Degree of Dynamic Stability of the Foot in Single-leg Support in Relation to the Foot Posture Index in Judokas

    Sponsor: Fundación Universidad Católica de Valencia San Vicente Mártir. Phase: . Conditions: Postural Balance, Foot Posture, Sports Injuries, Athletic Performance

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07160621: Culturally Adapted Mobile Treatment of Chronic Pain in Adolescent Survivors of Pediatric Cancer: A Randomized Clinical Trial

    Sponsor: St. Jude Children's Research Hospital. Phase: NA. Conditions: Childhood Cancer Survivor, Chronic Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05890716: AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)

    Sponsor: Idoven 1903 S.L.. Phase: . Conditions: Cardiomyopathies, Cardiac Arrest, Cardiac Arrhythmias, Sudden Cardiac Death

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06767306: Stereotactic Ablative Radiotherapy (XRT) and Immunotherapy for Oligometastatic Extracranial Melanoma

    Sponsor: Melanoma Institute Australia. Phase: PHASE2. Conditions: Melanoma Metastatic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06593106: Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial

    Sponsor: Vanderbilt-Ingram Cancer Center. Phase: NA. Conditions: Stage I Lung Cancer, Stage II Lung Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07460206: Pembrolizumab Plus Lenvatinib in REcurrent ccRCC Patients Failing permbroLizUmab aDjuvant trEatment

    Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica. Phase: PHASE2. Conditions: ccRCC

    full page →ctgov ↗
    ← prev
    page 5 of 96
    next →